<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Patten RK</submitter><pubmed_abstract>Women with PCOS have substantially greater symptoms of depression and anxiety, and a lower health-related quality of life (HRQoL) compared to women without PCOS. The aim of this study was to determine if high-intensity interval training (HIIT) could provide greater improvements in mental health outcomes than standard moderate-intensity continuous training (MICT). Twenty-nine overweight women with PCOS aged 18-45 years were randomly assigned to 12 weeks of either MICT (60-75% HR&lt;sub>peak&lt;/sub>, N = 15) or HIIT (> 90% HR&lt;sub>peak&lt;/sub>, N = 14). Outcome measures included symptoms of depression, anxiety and stress (DASS-21), general HRQoL (SF-36) and PCOS specific HRQoL (PCOSQ) collected at baseline and post-intervention. Reductions in depression (Δ - 1.7, P = 0.005), anxiety (Δ - 3.4, P &lt; 0.001) and stress (Δ - 2.4, P = 0.003) scores were observed in the HIIT group, while MICT only resulted in a reduction in stress scores (Δ - 2.9, P = 0.001). Reductions in anxiety scores were significantly higher in the HIIT group compared to the MICT group (β = - 2.24, P = 0.020). Both HIIT and MICT significantly improved multiple domain scores from the SF-36 and PCOSQ. This study highlights the potential of HIIT for improving mental health and HRQoL in overweight women with PCOS. HIIT may be a viable strategy to reduce symptoms of depression and anxiety in women with PCOS, however, large-scale studies are required to confirm these findings.Trial registration number: ACTRN12615000242527.</pubmed_abstract><journal>Scientific reports</journal><pagination>3025</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9944288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome.</pubmed_title><pmcid>PMC9944288</pmcid><pubmed_authors>McIlvenna LC</pubmed_authors><pubmed_authors>Hiam D</pubmed_authors><pubmed_authors>Patten RK</pubmed_authors><pubmed_authors>Stepto NK</pubmed_authors><pubmed_authors>Rosenbaum S</pubmed_authors><pubmed_authors>Parker AG</pubmed_authors><pubmed_authors>Moreno-Asso A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome.</name><description>Women with PCOS have substantially greater symptoms of depression and anxiety, and a lower health-related quality of life (HRQoL) compared to women without PCOS. The aim of this study was to determine if high-intensity interval training (HIIT) could provide greater improvements in mental health outcomes than standard moderate-intensity continuous training (MICT). Twenty-nine overweight women with PCOS aged 18-45 years were randomly assigned to 12 weeks of either MICT (60-75% HR&lt;sub>peak&lt;/sub>, N = 15) or HIIT (> 90% HR&lt;sub>peak&lt;/sub>, N = 14). Outcome measures included symptoms of depression, anxiety and stress (DASS-21), general HRQoL (SF-36) and PCOS specific HRQoL (PCOSQ) collected at baseline and post-intervention. Reductions in depression (Δ - 1.7, P = 0.005), anxiety (Δ - 3.4, P &lt; 0.001) and stress (Δ - 2.4, P = 0.003) scores were observed in the HIIT group, while MICT only resulted in a reduction in stress scores (Δ - 2.9, P = 0.001). Reductions in anxiety scores were significantly higher in the HIIT group compared to the MICT group (β = - 2.24, P = 0.020). Both HIIT and MICT significantly improved multiple domain scores from the SF-36 and PCOSQ. This study highlights the potential of HIIT for improving mental health and HRQoL in overweight women with PCOS. HIIT may be a viable strategy to reduce symptoms of depression and anxiety in women with PCOS, however, large-scale studies are required to confirm these findings.Trial registration number: ACTRN12615000242527.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-03-27T15:43:55.758Z</modification><creation>2025-04-04T18:59:53.608Z</creation></dates><accession>S-EPMC9944288</accession><cross_references><pubmed>36810865</pubmed><doi>10.1038/s41598-023-29503-1</doi></cross_references></HashMap>